2024-07-01 2025-06-30 2025-06-30 false 10890538 NEWAFRICA BIOENERGY LIMITED 2026-07-02 false iso4217:GBP xbrli:pure 10890538 2024-06-30 10890538 2025-06-30 10890538 2024-07-01 2025-06-30 10890538 2023-06-30 10890538 2024-06-30 10890538 2023-07-01 2024-06-30 10890538 bus:SmallEntities 2024-07-01 2025-06-30 10890538 bus:AuditExempt-NoAccountantsReport 2024-07-01 2025-06-30 10890538 bus:FullAccounts 2024-07-01 2025-06-30 10890538 bus:PrivateLimitedCompanyLtd 2024-07-01 2025-06-30 10890538 core:WithinOneYear 2025-06-30 10890538 core:AfterOneYear 2025-06-30 10890538 core:WithinOneYear 2024-06-30 10890538 core:AfterOneYear 2024-06-30 10890538 core:ShareCapital 2025-06-30 10890538 core:SharePremium 2025-06-30 10890538 core:RevaluationReserve 2025-06-30 10890538 core:OtherReservesSubtotal 2025-06-30 10890538 core:RetainedEarningsAccumulatedLosses 2025-06-30 10890538 core:ShareCapital 2024-06-30 10890538 core:SharePremium 2024-06-30 10890538 core:RevaluationReserve 2024-06-30 10890538 core:OtherReservesSubtotal 2024-06-30 10890538 core:RetainedEarningsAccumulatedLosses 2024-06-30 10890538 core:LandBuildings 2025-06-30 10890538 core:PlantMachinery 2025-06-30 10890538 core:Vehicles 2025-06-30 10890538 core:FurnitureFittings 2025-06-30 10890538 core:OfficeEquipment 2025-06-30 10890538 core:NetGoodwill 2025-06-30 10890538 core:IntangibleAssetsOtherThanGoodwill 2025-06-30 10890538 core:ListedExchangeTraded 2025-06-30 10890538 core:UnlistedNon-exchangeTraded 2025-06-30 10890538 core:LandBuildings 2024-06-30 10890538 core:PlantMachinery 2024-06-30 10890538 core:Vehicles 2024-06-30 10890538 core:FurnitureFittings 2024-06-30 10890538 core:OfficeEquipment 2024-06-30 10890538 core:NetGoodwill 2024-06-30 10890538 core:IntangibleAssetsOtherThanGoodwill 2024-06-30 10890538 core:ListedExchangeTraded 2024-06-30 10890538 core:UnlistedNon-exchangeTraded 2024-06-30 10890538 core:LandBuildings 2024-07-01 2025-06-30 10890538 core:PlantMachinery 2024-07-01 2025-06-30 10890538 core:Vehicles 2024-07-01 2025-06-30 10890538 core:FurnitureFittings 2024-07-01 2025-06-30 10890538 core:OfficeEquipment 2024-07-01 2025-06-30 10890538 core:NetGoodwill 2024-07-01 2025-06-30 10890538 core:IntangibleAssetsOtherThanGoodwill 2024-07-01 2025-06-30 10890538 core:ListedExchangeTraded 2024-07-01 2025-06-30 10890538 core:UnlistedNon-exchangeTraded 2024-07-01 2025-06-30 10890538 core:MoreThanFiveYears 2024-07-01 2025-06-30 10890538 core:Non-currentFinancialInstruments 2025-06-30 10890538 core:Non-currentFinancialInstruments 2024-06-30 10890538 dpl:CostSales 2024-07-01 2025-06-30 10890538 dpl:DistributionCosts 2024-07-01 2025-06-30 10890538 core:LandBuildings 2024-07-01 2025-06-30 10890538 core:PlantMachinery 2024-07-01 2025-06-30 10890538 core:Vehicles 2024-07-01 2025-06-30 10890538 core:FurnitureFittings 2024-07-01 2025-06-30 10890538 core:OfficeEquipment 2024-07-01 2025-06-30 10890538 dpl:AdministrativeExpenses 2024-07-01 2025-06-30 10890538 core:NetGoodwill 2024-07-01 2025-06-30 10890538 core:IntangibleAssetsOtherThanGoodwill 2024-07-01 2025-06-30 10890538 dpl:GroupUndertakings 2024-07-01 2025-06-30 10890538 dpl:ParticipatingInterests 2024-07-01 2025-06-30 10890538 dpl:GroupUndertakings core:ListedExchangeTraded 2024-07-01 2025-06-30 10890538 core:ListedExchangeTraded 2024-07-01 2025-06-30 10890538 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2024-07-01 2025-06-30 10890538 core:UnlistedNon-exchangeTraded 2024-07-01 2025-06-30 10890538 dpl:CostSales 2023-07-01 2024-06-30 10890538 dpl:DistributionCosts 2023-07-01 2024-06-30 10890538 core:LandBuildings 2023-07-01 2024-06-30 10890538 core:PlantMachinery 2023-07-01 2024-06-30 10890538 core:Vehicles 2023-07-01 2024-06-30 10890538 core:FurnitureFittings 2023-07-01 2024-06-30 10890538 core:OfficeEquipment 2023-07-01 2024-06-30 10890538 dpl:AdministrativeExpenses 2023-07-01 2024-06-30 10890538 core:NetGoodwill 2023-07-01 2024-06-30 10890538 core:IntangibleAssetsOtherThanGoodwill 2023-07-01 2024-06-30 10890538 dpl:GroupUndertakings 2023-07-01 2024-06-30 10890538 dpl:ParticipatingInterests 2023-07-01 2024-06-30 10890538 dpl:GroupUndertakings core:ListedExchangeTraded 2023-07-01 2024-06-30 10890538 core:ListedExchangeTraded 2023-07-01 2024-06-30 10890538 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2023-07-01 2024-06-30 10890538 core:UnlistedNon-exchangeTraded 2023-07-01 2024-06-30 10890538 core:NetGoodwill 2025-06-30 10890538 core:IntangibleAssetsOtherThanGoodwill 2025-06-30 10890538 core:LandBuildings 2025-06-30 10890538 core:PlantMachinery 2025-06-30 10890538 core:Vehicles 2025-06-30 10890538 core:FurnitureFittings 2025-06-30 10890538 core:OfficeEquipment 2025-06-30 10890538 core:AfterOneYear 2025-06-30 10890538 core:WithinOneYear 2025-06-30 10890538 core:ListedExchangeTraded 2025-06-30 10890538 core:UnlistedNon-exchangeTraded 2025-06-30 10890538 core:ShareCapital 2025-06-30 10890538 core:SharePremium 2025-06-30 10890538 core:RevaluationReserve 2025-06-30 10890538 core:OtherReservesSubtotal 2025-06-30 10890538 core:RetainedEarningsAccumulatedLosses 2025-06-30 10890538 core:NetGoodwill 2024-06-30 10890538 core:IntangibleAssetsOtherThanGoodwill 2024-06-30 10890538 core:LandBuildings 2024-06-30 10890538 core:PlantMachinery 2024-06-30 10890538 core:Vehicles 2024-06-30 10890538 core:FurnitureFittings 2024-06-30 10890538 core:OfficeEquipment 2024-06-30 10890538 core:AfterOneYear 2024-06-30 10890538 core:WithinOneYear 2024-06-30 10890538 core:ListedExchangeTraded 2024-06-30 10890538 core:UnlistedNon-exchangeTraded 2024-06-30 10890538 core:ShareCapital 2024-06-30 10890538 core:SharePremium 2024-06-30 10890538 core:RevaluationReserve 2024-06-30 10890538 core:OtherReservesSubtotal 2024-06-30 10890538 core:RetainedEarningsAccumulatedLosses 2024-06-30 10890538 core:NetGoodwill 2023-06-30 10890538 core:IntangibleAssetsOtherThanGoodwill 2023-06-30 10890538 core:LandBuildings 2023-06-30 10890538 core:PlantMachinery 2023-06-30 10890538 core:Vehicles 2023-06-30 10890538 core:FurnitureFittings 2023-06-30 10890538 core:OfficeEquipment 2023-06-30 10890538 core:AfterOneYear 2023-06-30 10890538 core:WithinOneYear 2023-06-30 10890538 core:ListedExchangeTraded 2023-06-30 10890538 core:UnlistedNon-exchangeTraded 2023-06-30 10890538 core:ShareCapital 2023-06-30 10890538 core:SharePremium 2023-06-30 10890538 core:RevaluationReserve 2023-06-30 10890538 core:OtherReservesSubtotal 2023-06-30 10890538 core:RetainedEarningsAccumulatedLosses 2023-06-30 10890538 core:AfterOneYear 2024-07-01 2025-06-30 10890538 core:WithinOneYear 2024-07-01 2025-06-30 10890538 core:Non-currentFinancialInstruments core:CostValuation 2024-07-01 2025-06-30 10890538 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2024-07-01 2025-06-30 10890538 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2024-07-01 2025-06-30 10890538 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2024-07-01 2025-06-30 10890538 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2024-07-01 2025-06-30 10890538 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2024-07-01 2025-06-30 10890538 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2024-07-01 2025-06-30 10890538 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2024-07-01 2025-06-30 10890538 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2024-07-01 2025-06-30 10890538 core:Non-currentFinancialInstruments core:CostValuation 2025-06-30 10890538 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2025-06-30 10890538 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2025-06-30 10890538 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2025-06-30 10890538 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2025-06-30 10890538 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2025-06-30 10890538 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2025-06-30 10890538 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2025-06-30 10890538 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2025-06-30 10890538 core:Non-currentFinancialInstruments core:CostValuation 2024-06-30 10890538 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2024-06-30 10890538 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2024-06-30 10890538 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2024-06-30 10890538 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2024-06-30 10890538 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2024-06-30 10890538 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2024-06-30 10890538 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2024-06-30 10890538 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2024-06-30 10890538 bus:Director1 2024-07-01 2025-06-30 10890538 bus:Director2 2024-07-01 2025-06-30 10890538 bus:Director3 2024-07-01 2025-06-30

NEWAFRICA BIOENERGY LIMITED

Registered Number
10890538
(England and Wales)

Unaudited Financial Statements for the Year ended
30 June 2025

NEWAFRICA BIOENERGY LIMITED
Company Information
for the year from 1 July 2024 to 30 June 2025

Directors | ASPREM, Mads Michael
| ERIKSSON, Bo Sören
| LOVHAUGEN, Odd Ivar

Registered Address | 47 Topsfield Parade Tottenham Lane
| London
| N8 8PT

Registered Number | 10890538 (England and Wales)

NEWAFRICA BIOENERGY LIMITED
Balance Sheet as at
30 June 2025

| Notes | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £ |  | £ |  | £
Fixed assets |  |  |  |  |  |  |  |
Tangible assets | 4 |  |  | 1,734 |  |  |  | 2,167
Investments | 5 |  |  | 674,284 |  |  |  | 930,123
|  |  |  | 676,018 |  |  |  | 932,290
Current assets |  |  |  |  |  |  |  |
Debtors |  | 167,504 |  |  |  | (79,461) |  |
Cash at bank and on hand |  | 453 |  |  |  | 9 |  |
|  | 167,957 |  |  |  | (79,452) |  |
Creditors amounts falling due within one year | 6 | (38,906) |  |  |  | (25,375) |  |
Net current assets (liabilities) |  |  |  | 129,051 |  |  |  | (104,827)
Total assets less current liabilities |  |  |  | 805,069 |  |  |  | 827,463
Creditors amounts falling due after one year | 7 |  |  | (292,462) |  |  |  | (297,722)
Net assets |  |  |  | 512,607 |  |  |  | 529,741
Capital and reserves |  |  |  |  |  |  |  |
Called up share capital |  |  |  | 420,654 |  |  |  | 262,119
Share premium |  |  |  | 707,935 |  |  |  | 707,935
Profit and loss account |  |  |  | (615,982) |  |  |  | (440,313)
Shareholders' funds |  |  |  | 512,607 |  |  |  | 529,741

- The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
- The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
- The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
- These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
- The directors have chosen to not file a copy of the company’s profit and loss account under section 444 (5A) Companies Act 2006.

The financial statements were approved and authorised for issue by the Board of Directors on 2 July 2026, and are signed on its behalf by:
ERIKSSON, Bo Sören Director Registered Company No. 10890538

NEWAFRICA BIOENERGY LIMITED
Notes to the Financial Statements
for the year ended 30 June 2025

1. | Accounting policies
--- | ---

| Statutory information
--- | ---
| The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the company information page. Company details: NEWAFRICA BIOENERGY LIMITED The registered office is 47 Topsfield Parade, Tottenham Lane, London, N8 8PT. Office Address: 34B York Way, London, N1 9AB, United Kingdom Email: contact@newafrica.com Website: www.newafricabioenergy.com

| Statement of compliance
--- | ---
| The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.

| Basis of preparation
--- | ---
| The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).

| Functional and presentation currency
--- | ---
| The financial statements are presented in sterling and this is the functional currency of the company.

| Turnover policy
--- | ---
| Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.

| Revenue from sale of goods
--- | ---
| Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.

| Employee benefits
--- | ---
| Contributions to defined contribution plans are expensed in the period to which they relate.

| Foreign currency translation
--- | ---
| Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.

| Tangible fixed assets and depreciation
--- | ---
| Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

|  | Reducing balance (%)
| Office Equipment | 20

| Investments
--- | ---
| Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value where the difference between cost and fair value is material. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.

2. | Average number of employees
--- | ---

|  | 2025 |  | 2024
| Average number of employees during the year | 1 |  | 2

3. | Further information regarding the company's income
--- | ---
| NAB have made big efforts in finding and developing new projects and made full proposals for two projects of which NAB has been elected developer and for the second NAB has been shortlisted. With reference to earlier developed projects have three of them been postponed. NAB continued to work with the leading forest owners and wood processors in the countries where it operates, provide new solutions for the biomass supply chain and their energy supply. All projects will provide significant amounts of energy for rural communities.

4. | Tangible fixed assets
--- | ---

|  | Office Equipment |  | Total
--- | --- | --- | --- | ---
|  | £ |  | £
| Cost or valuation
| At 01 July 24 | 5,254 |  | 5,254
| At 30 June 25 | 5,254 |  | 5,254
| Depreciation and impairment
| At 01 July 24 | 3,087 |  | 3,087
| Charge for year | 433 |  | 433
| At 30 June 25 | 3,520 |  | 3,520
| Net book value
| At 30 June 25 | 1,734 |  | 1,734
| At 30 June 24 | 2,167 |  | 2,167

5. | Fixed asset investments
--- | ---

|  | Other investments1 |  | Total
--- | --- | --- | --- | ---
|  | £ |  | £
| Cost or valuation
| At 01 July 24 | 930,123 |  | 930,123
| Disposals | (255,839) |  | (255,839)
| At 30 June 25 | 674,284 |  | 674,284
| Net book value
| At 30 June 25 | 674,284 |  | 674,284
| At 30 June 24 | 930,123 |  | 930,123

| Notes
--- | ---
| 1Other investments other than loans

6. | Creditors: amounts due within one year
--- | ---

|  | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £
| Trade creditors / trade payables | 4,164 |  | 4,351
| Bank borrowings and overdrafts | 3,423 |  | 3,473
| Taxation and social security | 7,829 |  | 4,744
| Other creditors | 2,708 |  | 3,941
| Accrued liabilities and deferred income | 20,782 |  | 8,866
| Total | 38,906 |  | 25,375

| Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method. Accounts Payable 2,185 Other Creditors 1,979 PAYE 5,863 Bank Loans and overdrafts - Current Portion 3,423 Foreign Tax Payable 1,966 Director's Loan - Short term (5,039) Accruals 20,782 Other creditors 2,708 ________ TOTAL CREDITORS WITHIN ONE YEAR £ 33,867

7. | Creditors: amounts due after one year
--- | ---

|  | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £
| Bank borrowings and overdrafts | 107,104 |  | 106,412
| Other creditors | 185,358 |  | 191,310
| Total | 292,462 |  | 297,722

| Long Term Bank Loan 3,454 Lux Bank Loan Account 103,650 Loan - SCAF 185,358 ________ TOTAL CREDITORS AFTER ONE YEAR £292,462